Immutep (IMMP) EBITDA Margin (2016 - 2017)

Immutep filings provide 2 years of EBITDA Margin readings, the most recent being 370.98% for Q2 2017.

  • On a quarterly basis, EBITDA Margin rose 123442.0% to 370.98% in Q2 2017 year-over-year; TTM through Jun 2017 was 378.21%, a N/A change, with the full-year FY2025 number at 594.28%, down 4972.0% from a year prior.
  • EBITDA Margin hit 370.98% in Q2 2017 for Immutep, down from 137.35% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 137.35% in Q1 2017 to a low of 1605.41% in Q2 2016.